Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

90 study records (showing up to 30 per record type)

• Registered trial NCT05840848 Completed (results not assessed here)
  Effect of Iron and Zinc Supplementation on B-carotene Bioavailability in Healthy Males
  Condition or outcome area: Bioavailability
  2017-11-21 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05882084 Not completed: Recruiting
  Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity
  Condition or outcome area: Photoaging
  2023-07-24 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05376501 Completed (results not assessed here)
  A Study to Evaluate the Effect of Astaxanthin in Healthy Participants
  Condition or outcome area: Healthy
  2022-06-08 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05437601 Phase 2 Completed (results not assessed here)
  Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis
  Condition or outcome area: Osteoarthritis, Knee
  2022-07-31 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05409092 Completed (results not assessed here)
  Astaxanthin, Exercise Inflammation, Skin Health
  Condition or outcome area: Inflammatory Response|Metabolic Disturbance|Immune Suppression
  2022-01-19 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00342992 Completed (results not assessed here)
  Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
  Condition or outcome area: Stroke|Diabetes Mellitus|Heart Disease|Cancer
  1995-03-03 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03945526 Phase 1 Completed (results not assessed here)
  Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients
  Condition or outcome area: Cerebral Stroke|Malondialdehyde|Oxidative Stress
  2010-03-23 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03433092 Completed (results not assessed here)
  Serum Carotenoids and Risk of Gastrointestinal Tract Cancer: Meta-analysis of Ten Studies
  Condition or outcome area: Gastrointestinal Tract Cancer
  2017-11-01 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02276014 Completed (results not assessed here)
  Effect of SNPs in the BCMO1 Enzyme
  Condition or outcome area: Beta-carotene Bioavailability|Vitamin A Deficiency
  2012-04 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01381276 Phase 2 Completed (results not assessed here)
  Vitamin A Absorption From Cassava in Women
  Condition or outcome area: Vitamin A Deficiency
  2011-06 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00872664 Completed (results not assessed here)
  Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids
  Condition or outcome area: Retinopathy of Prematurity
  2009-09 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00680212 Phase 2 Completed (results not assessed here)
  Vitamin A Equivalence of Plant Carotenoids in Children
  Condition or outcome area: Vitamin A Deficiency
  2008-07 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00636038 Phase 1 Completed (results not assessed here)
  Bioavailability of Yellow Maize Carotenoids in Humans
  Condition or outcome area: Vitamin A Status
  2008-01 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00356252 Completed (results not assessed here)
  Biological Functions of Carotenoids in Humans
  Condition or outcome area: Oxidative DNA Damage
  2002-04 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03807050 Completed (results not assessed here)
  Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin
  Condition or outcome area: Absorption; Chemicals
  2018-11-19 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03368872 Completed (results not assessed here)
  Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
  Condition or outcome area: Sarcopenia
  2015-10 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03310359 Completed (results not assessed here)
  Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects
  Condition or outcome area: Metabolic Syndrome X
  2016-07 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02373111 Completed (results not assessed here)
  Effects of Isoflavone Combined With Astaxanthin on Skin Aging
  Condition or outcome area: Ageing|Photo-aging
  2015-03 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02310087 Completed (results not assessed here)
  Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures
  Condition or outcome area: Infertility, Male
  2014-11 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04697355 Completed (results not assessed here)
  Effect of Naringenin and Beta Carotene on Energy Expenditure
  Condition or outcome area: Energy Expenditure|Safety Issues|Glucose Metabolism
  2021-04-19 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03492593 Completed (results not assessed here)
  Lycopene and Beta-carotene Metabolism in the Digestive Tract of Healthy Men
  Condition or outcome area: Digestion Chambers|Stability and Metabolism of Carotenoids and Vitamin E
  2014-09 · Subject: Lycopene; all-trans-Lycopene; Lycopene all-trans-; C05432; Spectrum4_001998; KBio2_002146; Lycopene, all-trans- (8CI); BSPBio_003389; (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene; trans-Lycopene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03492593 Completed (results not assessed here)
  Lycopene and Beta-carotene Metabolism in the Digestive Tract of Healthy Men
  Condition or outcome area: Digestion Chambers|Stability and Metabolism of Carotenoids and Vitamin E
  2014-09 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02550483 Completed (results not assessed here)
  Novel Metabolites of Beta-Carotene and Lycopene
  Condition or outcome area: Healthy
  2015-09 · Subject: Lycopene; all-trans-Lycopene; Lycopene all-trans-; C05432; Spectrum4_001998; KBio2_002146; Lycopene, all-trans- (8CI); BSPBio_003389; (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene; trans-Lycopene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02550483 Completed (results not assessed here)
  Novel Metabolites of Beta-Carotene and Lycopene
  Condition or outcome area: Healthy
  2015-09 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00712647 Phase 4 Completed (results not assessed here)
  Carotene and Retinol Efficacy Trial
  Condition or outcome area: Lung Cancer
  1985-05 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00198822 Phase 3 Completed (results not assessed here)
  Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
  Condition or outcome area: Vitamin A Deficiency|Maternal Mortality|Infant Mortality
  2001-08 · Subject: Oleovitamin A; Retinol; Bentavit A; I14-19488; Avitol; 17104-91-5; Dofsol; all-trans-Vitamin A1; IDI1_000486; FPIPGXGPPPQFEQ-OVSJKPMPSA-N · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00198822 Phase 3 Completed (results not assessed here)
  Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
  Condition or outcome area: Vitamin A Deficiency|Maternal Mortality|Infant Mortality
  2001-08 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00169845 Phase 3 Completed (results not assessed here)
  Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
  Condition or outcome area: Neoplasms
  1994-10 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00169845 Phase 3 Completed (results not assessed here)
  Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
  Condition or outcome area: Neoplasms
  1994-10 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00128804 Completed (results not assessed here)
  The STOVITA Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Ileostomy Patients
  Condition or outcome area: Healthy|Ileostomy
  2004-07 · Subject: Beta-Carotene; beta-Carotene; all-trans-beta-Carotene; Carotene Base 80S; BSPBio_003404; .beta., .beta.-Carotene; CAS-7235-40-7; .beta.-Carotene; SR-01000763803-4; H982 · open the ingredient record · ClinicalTrials.gov
• Systematic review registration CRD42023449079 Registered protocol, no results here: Review Ongoing
  Complex of Lutein and Zeaxanthin to prevent Age-related Macular Degeneration(AMD) : A Systematic Review and Meta-analysis
  Condition or outcome area: Age-related Macular Degeneration (AMD) is the leading cause of visual loss in industrialised countries. Present treatments are limited and costly. So AMD's prevention strategy will become more important.
  2023-08-06 · Subject: Zeaxanthine; Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp · open the ingredient record
• Systematic review registration CRD42023485956 Registered protocol, no results here: Review Ongoing
  Assessment of biological carotenoid levels as biomarkers of dietary intake: a systematic review and meta-analysis protocol
  Condition or outcome area: Assessment of dietary intake is known to involve a number of challenges and limitations, particularly related to the subjectivity of dietary collection. A reliable, accurate and replicable method of dietary intake, particularly looking at the consumption of key nutrients present in healthy diets, such as fruits and vegetables, would provide enormous advantages to the field of nutrition and health. Carotenoids are highly prevalent in these foods groups and are considered of interest as a marker o
  2023-12-07 · Subject: Zeaxanthine; Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp · open the ingredient record
• Systematic review registration CRD42023453837 Registered protocol, no results here: Review Ongoing
  Effect of malaria on beta-carotene levels
  Condition or outcome area: Malaria is caused in humans by five species of single-celled eukaryotic Plasmodium parasites (mainly Plasmodium falciparum and Plasmodium vivax) that are transmitted by the bite of Anopheles spp. mosquitoes. Malaria remains one of the most serious infectious diseases; it threatens nearly half of the world's population and led to hundreds of thousands of deaths in 2015, predominantly among children in Africa. β-Carotene (beta-carotene) is an organic, strongly coloured red-orange pigment abundant
  2023-08-22 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42023422784 Registered protocol, no results here: Review Completed published
  Assess the effectiveness of beta-carotene on cognitive function through a systematic review based on machine learning
  Condition or outcome area: The review takes into consideration health subjects and subjects with mental disorders.
  2023-05-15 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42023418843 Registered protocol, no results here: Review Ongoing
  The effects of nutrition interventions on adverse perinatal outcomes: an umbrella reviews of systematic review and meta-analysis
  Condition or outcome area: To evaluate the quality of evidence and effectiveness of all available studies on nutrition interventions for the effect of adverse perinatal outcomes.
  2023-04-30 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42023470793 Registered protocol, no results here: Review Ongoing
  Astaxanthin and Improvement of Dementia: A Systematic Review of Current Clinical Trials
  Condition or outcome area: Cognitive impairment, reported subjectively and/ or objectively according to valid instrument/ testing
  2023-10-19 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023437319 Registered protocol, no results here: Review Ongoing
  Effect of astaxanthin supplementation on plasma metabolites, inflammation, oxidative stress, fat and carbohydrate oxidation, physical performance and lipid profile in male during Exercise : A Systematic Review and Meta-Analysis
  Condition or outcome area: Effect of astaxanthin supplementation on plasma metabolites, inflammation, oxidative stress, fat and carbohydrate oxidation, physical performance and lipid profile in male during Exercise
  2023-06-27 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023411548 Registered protocol, no results here: Review Completed not published
  Effects of Astaxanthin on Pathology-Related Biomarkers in Middle-Aged and Elderly Adults: A Systematic Review and Meta-Analysis
  Condition or outcome area: The rise in global life expectancy in recent decades has led to an aging population with an increased prevalence of chronic diseases, cognitive impairment, and disability. Oxidative stress, which results from an imbalance between oxidants and antioxidants, can lead to macromolecular damage, disruption of redox signaling and cellular control, and markers commonly observed in various diseases such as metabolic syndrome, chronic fatigue syndrome, neurodegenerative disorders, cardiovascular diseases
  2023-06-16 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023409269 Registered protocol, no results here: Review Ongoing
  The effect of Astaxanthin intake on cardio-metabolic risk factors, Inflammatory, and liver enzymes: a systematic review and meta-analysis
  Condition or outcome area: unhealthy adults with metabolic syndrome and related diseases
  2023-03-29 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023428043 Registered protocol, no results here: Review Ongoing
  The effects of astaxanthin supplementation on liver enzymes levels: A systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: Astaxanthin belongs to a group of carotenoids that are oxidized (1-3). It is a natural compound found in various sources such as algae, fish and birds (1).
  2023-05-31 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42020197594 Registered protocol, no results here: Review Ongoing
  Systematic review of the evidence on lutein/zeaxanthin intake and human macular pigment optical density
  Condition or outcome area: optimal ocular tissue health
  2020-08-16 · Subject: Zeaxanthine; Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp · open the ingredient record
• Systematic review registration CRD42020197594 Registered protocol, no results here: Review Ongoing
  Systematic review of the evidence on lutein/zeaxanthin intake and human macular pigment optical density
  Condition or outcome area: optimal ocular tissue health
  2020-08-16 · Subject: Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp; Zeagold · open the ingredient record
• Systematic review registration CRD42016045942 Registered protocol, no results here: Review Ongoing
  Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants [Cochrane Protocol]
  Condition or outcome area: The Cochrane Neonatal Group
  2016-08-15 · Subject: Zeaxanthine; Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp · open the ingredient record
• Systematic review registration CRD42016045942 Registered protocol, no results here: Review Ongoing
  Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants [Cochrane Protocol]
  Condition or outcome area: The Cochrane Neonatal Group
  2016-08-15 · Subject: Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp; Zeagold · open the ingredient record
• Systematic review registration CRD42022344012 Registered protocol, no results here: Review Ongoing
  Association of carotenoids with risk of gastric cancer: A meta-analysis.
  Condition or outcome area: Gastric cancer.
  2022-07-15 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42022343482 Registered protocol, no results here: Review Ongoing
  Intakes or circulating levels of vitamin C, vitamin E, and beta-carotene and the risk of type 2 diabetes: a systematic review and meta-analysis
  Condition or outcome area: Type 2 diabetes (T2D), insulin secretion/deficiency, insulin resistance
  2022-07-11 · Subject: Vitamin c; Ascorbic Acid; l-ascorbic acid; ascorbic acid; 50-81-7; L-ascorbate; Ascoltin; ascorbate; Ascorbicap; Cevitamic acid · open the ingredient record
• Systematic review registration CRD42022343482 Registered protocol, no results here: Review Ongoing
  Intakes or circulating levels of vitamin C, vitamin E, and beta-carotene and the risk of type 2 diabetes: a systematic review and meta-analysis
  Condition or outcome area: Type 2 diabetes (T2D), insulin secretion/deficiency, insulin resistance
  2022-07-11 · Subject: Vitamin e; Alpha-Tocopherol; alpha-Tocopherol; 59-02-9; D-alpha-Tocopherol; 5,7,8-Trimethyltocol; (+)-alpha-Tocopherol; 2074-53-5; alpha Tocopherol; Phytogermine · open the ingredient record
• Systematic review registration CRD42022343482 Registered protocol, no results here: Review Ongoing
  Intakes or circulating levels of vitamin C, vitamin E, and beta-carotene and the risk of type 2 diabetes: a systematic review and meta-analysis
  Condition or outcome area: Type 2 diabetes (T2D), insulin secretion/deficiency, insulin resistance
  2022-07-11 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42022340579 Registered protocol, no results here: Review Ongoing
  Carrot and carotene and multiple health outcomes: An umbrella review of the evidence
  Condition or outcome area: Carrot is consumed widely and deeply loved by people. Carrot is recognized to have multiple beneficial effects on human health because it contains many important nutrients, including antioxidant ingredients, fiber, and vitamins. Therefore, they play an important role in maintaining health and preventing cardiovascular diseases (CVDs). Carotenes are the most important nutritional components of carrots. β-Carotene is partly directly converted into vitamin A once ingested in the intestinal tract or
  2022-07-02 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42022318388 Registered protocol, no results here: Review Ongoing
  Vitamin C, Vitamin E, β-carotene and risk of Parkinson’s disease: a systematic review and dose-response meta-analysis of observational studies
  Condition or outcome area: Recent evidence suggests that oxidative stress plays an important role in the pathogenesis of the disease. Vitamin C, vitamin E and beta carotene have always been the research focus of antioxidants. However, data on the relationship between dietary and supplement intake of vitamin C, vitamin E and beta carotene and the risk of Parkinson's disease are contradictory. Therefore, we will conduct a systematic review and meta-analysis of observational studies to assess the association between the inta
  2022-04-17 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42021287694 Registered protocol, no results here: Review Ongoing
  The association of plasma carotenoids and vitamins with risk of age-related macular degeneration
  Condition or outcome area: Age-related macular degeneration
  2021-11-26 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42021285084 Registered protocol, no results here: Review Ongoing
  Effect of carotenoids supplementation on type 2 diabetes and glycemic profile
  Condition or outcome area: Diabetes mellitus (DM) is a chronic metabolic disorder that results from defects in insulin secretion, insulin signaling, or both, and it is characterized by hyperglycemia and the consequent abnormalities in carbohydrate, lipid, and protein metabolism. Because of uncontrolled hyperglycemia and its consequent complications, DM is currently one of the main leading causes of death.
  2021-11-13 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42021259354 Registered protocol, no results here: Review Ongoing
  Association between beta carotene supplementation and mortality: a systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: Mortality from any cause in healthy subjects or subjects diagnosed with a specific disease
  2021-07-06 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42020188539 Registered protocol, no results here: Review Ongoing
  Effects of dietary fats on the bioaccessibility and bioavailability of the carotenoids. A Systematic Review and Meta-analysis of clinical trial and in-vitro research
  Condition or outcome area: Nutrients (carotenoids) absorption
  2020-07-05 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42019122137 Registered protocol, no results here: Review Ongoing
  Dose-response analysis of dietary vitamin A and beta-carotene intake with the risk of lung cancer
  Condition or outcome area: Lung cancer is a leading cause of cancer mortality worldwide, with a complex carcinogenesis, and the overall survival rate is still extremely poor. The incidence rate was 62.6/100, 000 per year while the death rate was 50.6/100, 000 per year worldwide in 2011. Therefore, to prevent lung cancer is an important matter in society today.
  2019-01-30 · Subject: Beta-carotene; Beta-Carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Solatene; Betacarotene; Provatene; Carotaben; Provitamin A · open the ingredient record
• Systematic review registration CRD42022356955 Registered protocol, no results here: Review Ongoing
  Efficacy of astaxanthin supplementary on subjective fatigue, exercise performance, and cognitive function: A meta-analysis of randomizedcontrolled trials
  Condition or outcome area: Astaxanthin, extracted from Haematococcus pluvialis (H. pluvialis), is a natural nutrient of β-carotenoid, which possesses abundant beneficial properties, such as antioxidant, anti-inflammatory, and lipid-lowering activities. Recent randomized studies have reported the effectiveness of astaxanthin on improvement of fatigue, enhancement of exercise, as well as cognitive fitness. Actually, there were interactions among subjective fatigue, physical performance, and cognitive fitness. The less subje
  2022-09-10 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42022335796 Registered protocol, no results here: Review Ongoing
  Efficacy of astaxanthin in animal models of type 2 diabetes mellitus: a systematic review and meta-analysis
  2022-06-07 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42021275708 Registered protocol, no results here: Review Ongoing
  Impact of Astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: Hypertension (HTN) is the common modifiable risk factor for cardiovascular disease, stroke, renal dysfunction, and mortality worldwide. Threshold values used to define hypertension have been recently reduced as Systolic blood pressure (SBP) ≥ 130 mmHg or diastolic blood pressure (DBP) ≥ 80 mmHg. In 2010, the global prevalence of HTN was 31.1%. It has an increasing rate due to the population aging and rising exposure to lifestyle risk factors, especially in low- and middle-income countries.
  2021-09-29 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42020215881 Registered protocol, no results here: Review Completed published
  A systematic review of astaxanthin on the risk factors of metabolic syndrome
  Condition or outcome area: Risk factors of metabolic syndrome, type 2 diabetes mellitus
  2020-12-20 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42021267817 Registered protocol, no results here: Review Completed published
  Nutrition-related health outcomes of sweet potato (Ipomoea batatas) consumption: A systematic review
  Condition or outcome area: Sweet potatoes are common staple food worldwide, and they rich in beta-carotene, and anthocyanins. Consumption of sweet potato may contribute to health effects in humans. The nutrition-related outcomes of sweet potato consumption among healthy people and people affected by chronic disease will be evaluated by reviewing relevant literature. Sweet potato can benefit cardiometabolic aspects, psychocardiological indicators, various type of cancer and human gut microbial diversity. For example, it ha
  2021-08-13 · Subject: Gan Shu; 甘薯; Sweet Potato; Ipomoea Batatas · open the herb record
• Publication PMID 36500974 Research model: Animal Experiment
  Evaluation of the Anti-Obesity Effect of Zeaxanthin and Exercise in HFD-Induced Obese Rats
  Condition or outcome area: Obesity; obesity
  Nutrients · 2022 · Subject: Zeaxanthine; Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp · open the ingredient record · DOI 10.3390/nu14234944
• Publication PMID 34047728 Research model: Cell Experiment
  Zeaxanthin promotes browning by enhancing mitochondrial biogenesis through the PKA pathway in 3T3-L1 adipocytes
  Condition or outcome area: obesity; Obesity; mitochondrial dysfunction; systemic lipid metabolism disorders
  Food Funct · 2021 · Subject: Zeaxanthine; Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp · open the ingredient record · DOI 10.1039/d1fo00524c
• Publication PMID 33689686 Research model: Animal Experiment
  A novel gastroprotective effect of zeaxanthin against stress-induced gastritis in male rats targeting the expression of HIF-1α, TFF-1 and MMP-9 through PI3K/Akt/JNK signaling pathway
  Condition or outcome area: ulcer; gastritis; gastric mucosal damage
  Life Sci · 2021 · Subject: Zeaxanthine; Zeaxanthin; 144-68-3; Anchovyxanthin; Zeaxanthol; all-trans-Zeaxanthin; Xanthophyll 3; Beta,beta-carotene-3,3'-diol; Luteinofta; Optisharp · open the ingredient record · DOI 10.1016/j.lfs.2021.119297
• Publication PMID 36354983 Research model: Cell Experiment
  Astaxanthin Exerts Immunomodulatory Effect by Regulating SDH-HIF-1α Axis and Reprogramming Mitochondrial Metabolism in LPS-Stimulated RAW264.7 Cells
  Condition or outcome area: inflammatory diseases; mitochondrial dysfunction; metabolic disorders
  Mar Drugs · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md20110660
• Publication PMID 36008933 Research model: Animal & Cell Experiment
  Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose-Derived Stromal Cells Isolated from Equine Metabolic Syndrome Affected Horses by Targeting Mitochondrial Biogenesis
  Condition or outcome area: metabolic syndrome; mitochondrial dysfunction
  Biomolecules · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/biom12081039
• Publication PMID 35267937 Research model: Animal & Cell Experiment
  Astaxanthin Attenuates the Changes in the Expression of MicroRNAs Involved in the Activation of Hepatic Stellate Cells
  Condition or outcome area: liver fibrosis; aHSC
  Nutrients · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/nu14050962
• Publication PMID 35204257 Research model: Cell Experiment
  Astaxanthin Sensitizes Low SOD2-Expressing GBM Cell Lines to TRAIL Treatment via Pathway Involving Mitochondrial Membrane Depolarization
  Condition or outcome area: cancer; tumor; glioblastoma multiforme
  Antioxidants (Basel) · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/antiox11020375
• Publication PMID 35038495 Research model: Animal & Cell Experiment
  A smart cauliflower-like carrier for astaxanthin delivery to relieve colon inflammation
  Condition or outcome area: colitis; ulcerative colitis; tumor
  J Control Release · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.jconrel.2022.01.014
• Publication PMID 34940651 Research model: Animal Experiment
  Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
  Condition or outcome area: benign prostatic hyperplasia
  Mar Drugs · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md19120652
• Publication PMID 34825683 Research model: Animal Experiment
  Astaxanthin alleviates inflammatory pain by regulating the p38 mitogen-activated protein kinase and nuclear factor-erythroid factor 2-related factor/heme oxygenase-1 pathways in mice
  Condition or outcome area: inflammation; Inflammatory pain; thermal hyperalgesia; inflammatory pain; Complete Freund's adjuvant
  Food Funct · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1039/d1fo02326h
• Publication PMID 34684576 Research model: Animal Experiment
  Astaxanthin Inhibits Diabetes-Triggered Periodontal Destruction, Ameliorates Oxidative Complications in STZ-Injected Mice, and Recovers Nrf2-Dependent Antioxidant System
  Condition or outcome area: periodontal destruction; hyperglycemia-triggered periodontal destruction; type I diabetes; diabetic; type I diabetic; hyperglycemia; hyperglycemia-associated chronic complications; diabetes-associated periodontal destruction; diabetes; periodontitis
  Nutrients · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/nu13103575
• Publication PMID 34681695 Research model: Animal Experiment
  Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity
  Condition or outcome area: non-alcoholic steatohepatitis; liver fibrosis; non-alcoholic fatty liver disease; steatosis
  Int J Mol Sci · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/ijms222011037
• Publication PMID 34677433 Research model: Animal Experiment
  Astaxanthin Provides Antioxidant Protection in LPS-Induced Dendritic Cells for Inflammatory Control
  Condition or outcome area: sepsis
  Mar Drugs · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md19100534
• Publication PMID 34651285 Research model: Animal Experiment
  Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2
  Condition or outcome area: hepatic steatosis
  J Physiol Biochem · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1007/s13105-021-00850-9
• Publication PMID 34439521 Research model: Cell Experiment
  Astaxanthin Inhibits Autophagic Cell Death Induced by Bisphenol A in Human Dermal Fibroblasts
  Condition or outcome area: oxidative stress-related diseases
  Antioxidants (Basel) · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/antiox10081273
• Publication PMID 34204220 Research model: Animal Experiment
  Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction
  Condition or outcome area: sepsis
  Mar Drugs · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md19060346
• Publication PMID 33530505 Research model: Animal Experiment
  Astaxanthin Prevents Atrophy in Slow Muscle Fibers by Inhibiting Mitochondrial Reactive Oxygen Species via a Mitochondria-Mediated Apoptosis Pathway
  Condition or outcome area: muscle atrophy
  Nutrients · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/nu13020379
• Publication PMID 33505592 Research model: Animal Experiment
  Astaxanthin Alleviates Ochratoxin A-Induced Cecum Injury and Inflammation in Mice by Regulating the Diversity of Cecal Microbiota and TLR4/MyD88/NF- κ B Signaling Pathway
  Oxid Med Cell Longev · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1155/2021/8894491
• Publication PMID 33359248 Research model: Animal & Cell Experiment
  Astaxanthin inhibits microglia M1 activation against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-31-5p
  Life Sci · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.lfs.2020.118943
• Publication PMID 33326114 Research model: Animal Experiment
  Astaxanthin ameliorates oxidative stress and neuronal apoptosis via SIRT1/NRF2/Prx2/ASK1/p38 after traumatic brain injury in mice
  Condition or outcome area: Brain oedema; traumatic brain injury; brain injury
  Br J Pharmacol · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1111/bph.15346
• Publication PMID 33269751 Research model: Animal Experiment
  Astaxanthin alleviates pathological brain aging through the upregulation of hippocampal synaptic proteins
  Neural Regen Res · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.4103/1673-5374.300460
• Publication PMID 33132140 Research model: Animal Experiment
  Astaxanthin improves serum cytokine expression and semen quality of diabetes mellitus KKAy mice
  Condition or outcome area: diabetes mellitus; infertility; KKAy
  Chem Biol Interact · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.cbi.2020.109303
• Publication PMID 33047770 Research model: Animal Experiment
  Inflammation response after the cessation of chronic arsenic exposure and post-treatment of natural astaxanthin in liver: potential role of cytokine-mediated cell-cell interactions
  Condition or outcome area: liver injury
  Food Funct · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1039/d0fo01223h
• Publication PMID 33008094 Research model: Cell Experiment
  Astaxanthin Suppresses PM2.5-Induced Neuroinflammation by Regulating Akt Phosphorylation in BV-2 Microglial Cells
  Condition or outcome area: neurological disorders; Parkinson's disease; dementia; Alzheimer's disease
  Int J Mol Sci · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/ijms21197227
• Publication PMID 32998286 Research model: Cell Experiment
  Astaxanthin Inhibits p70 S6 Kinase 1 Activity to Sensitize Insulin Signaling
  Condition or outcome area: hyperglycemia; diabetic
  Mar Drugs · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md18100495
• Publication PMID 32937179 Research model: Animal Experiment
  Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy
  Condition or outcome area: diabetic nephropathy; diabetes mellitus; Diabetic nephropathy
  Eur J Pharm Biopharm · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.ejpb.2020.09.005
• Publication PMID 32918989 Research model: Animal Experiment
  Protective effect of astaxanthin against SnS2 nanoflowers induced testes toxicity by suppressing RIPK1-RIPK3-MLKL signaling in mice
  Condition or outcome area: inflammation
  Food Chem Toxicol · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.fct.2020.111736
• Publication PMID 32857080 Research model: Animal Experiment
  Astaxanthin attenuates oxidative stress and immune impairment in D-galactose-induced aging in rats by activating the Nrf2/Keap1 pathway and suppressing the NF-κB pathway
  Condition or outcome area: immune impairment
  Food Funct · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1039/d0fo01663b
• Publication PMID 32801029 Research model: Animal & Cell Experiment
  Astaxanthin inhibits alcohol-induced inflammation and oxidative stress in macrophages in a sirtuin 1-dependent manner
  Condition or outcome area: tumor
  J Nutr Biochem · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.jnutbio.2020.108477
• Publication PMID 32784629 Research model: Cell Experiment
  Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer
  Condition or outcome area: tumor; prostate cancer; PCa
  Mar Drugs · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md18080415